-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998615 | Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8), Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8), |
|||
| A998616 | Anti-CXCL8 / IL-8 Reference Antibody (HuMax-IL8), Anti-CXCL8 / IL-8 Reference Antibody (HuMax-IL8), |
|||
| A998617 | Anti-CXCL9 Reference Antibody (Novimmune patent anti-CXCL9), Anti-CXCL9 Reference Antibody (Novimmune patent anti-CXCL9), |
|||
| A998618 | Anti-CXCR3 / GPR9 / CD183 Reference Antibody (Genzyme patent anti-CXCR3), Anti-CXCR3 / GPR9 / CD183 Reference Antibody (Genzyme patent anti-CXCR3), |
|||
| A998619 | Anti-CXCR4 / CD184 Reference Antibody (Dana-Farber patent anti-CXCR4), Anti-CXCR4 / CD184 Reference Antibody (Dana-Farber patent anti-CXCR4), |
|||
| A998620 | Anti-CXCR4 / CD184 Reference Antibody (ulocuplumab), Anti-CXCR4 / CD184 Reference Antibody (ulocuplumab), |
|||
| A998621 | Anti-CXCR5 / CD185 Reference Antibody (SAR113244), Anti-CXCR5 / CD185 Reference Antibody (SAR113244), |
|||
| A998622 | Anti-CYR61 / CCN1 Reference Antibody (Roche patent anti-CCN1), Anti-CYR61 / CCN1 Reference Antibody (Roche patent anti-CCN1), |
|||
| A998624 | Anti-DC-SIGN / CD209 Reference Antibody (INSERM patent anti-DC-SIGN), Anti-DC-SIGN / CD209 Reference Antibody (INSERM patent anti-DC-SIGN), |
|||
| A998623 | Anti-DCBLD2 / ESDN Reference Antibody (FA19-1), Anti-DCBLD2 / ESDN Reference Antibody (FA19-1), |
|||
| A998625 | Anti-DCSTAMP Reference Antibody (U.Rochester patent anti-DC-STAMP), Anti-DCSTAMP Reference Antibody (U.Rochester patent anti-DC-STAMP), |
|||
| A998626 | Anti-DDR1 / CD167a Reference Antibody (Imperial College anti-DDR1), Anti-DDR1 / CD167a Reference Antibody (Imperial College anti-DDR1), |
|||
| A998627 | Anti-DKK1 Reference Antibody (BHQ-880), Anti-DKK1 Reference Antibody (BHQ-880), |
|||
| A998628 | Anti-DLK1 Reference Antibody (LIV-1205), Anti-DLK1 Reference Antibody (LIV-1205), |
|||
| A998629 | Anti-DLL3 Reference Antibody (Dragonfly patent anti-DLL3), Anti-DLL3 Reference Antibody (Dragonfly patent anti-DLL3), |
|||
| A998630 | Anti-DLL3 Reference Antibody (rovalpituzumab), Anti-DLL3 Reference Antibody (rovalpituzumab), |
|||
| A666736 | Anti-DLL4 & VEGF Reference Antibody (Navicixizumab), Target:DLL4&VEGF,Uniprot:Q9NR61&P15692,Species:Human,isotype:IgG-like Anti-DLL4 & VEGF Reference Antibody (Navicixizumab), Target:DLL4&VEGF,Uniprot:Q9NR61&P15692,Species:Human,isotype:IgG-like |
|||
| A998631 | Anti-DLL4 Reference Antibody (demcizumab), Anti-DLL4 Reference Antibody (demcizumab), |
|||
| A998632 | Anti-DLL4 Reference Antibody (enoticumab), Anti-DLL4 Reference Antibody (enoticumab), |
|||
| A998633 | Anti-DLL4 Reference Antibody (navicixizumab), Anti-DLL4 Reference Antibody (navicixizumab), |
